Evidence map›Paper›PMID 26063856›Full record

ArticleJournal of clinical microbiology2015

Identification of Highly Pathogenic Microorganisms by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry: Results of an Interlaboratory Ring Trial.

Peter Lasch, Tara Wahab, Sandra Weil, Bernadett Pályi, Herbert Tomaso, Sabine Zange, Beathe Kiland Granerud, Michal Drevinek, Branko Kokotovic, Matthias Wittwer and 5 more

Abstract readMulticenter Study
In one paragraph

Article in Journal of clinical microbiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. TrackingACS omega · 2026
    Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Discrimination ofMicroorganisms · 2021
    Article
  7. Review
  8. Article
  9. Yersinia pestis: the Natural History of Plague.Clinical microbiology reviews · 2020
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Recent applications of mass spectrometry in bacterial lipidomics.Analytical and bioanalytical chemistry · 2020
    Review
  15. Proteomics ofMicroorganisms · 2020
    Article
  16. Article
  17. Article
  18. MALDI-MS: Emerging roles in pathology and laboratory medicine.Clinical mass spectrometry (Del Mar, Calif.) · 2019
    Review
  19. Article
  20. Review of the impact of MALDI-TOF MS in public health and hospital hygiene, 2018.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Peter LaschRobert Koch Institute, Proteomics and Spectroscopy (ZBS 6), Berlin, Germany.
Tara WahabPublic Health Agency of Sweden, Solna, Sweden.
Sandra WeilAustrian Agency for Health and Food Safety, Vienna, Austria.
Bernadett PályiNational Center for Epidemiology, Department of Bacteriology, Budapest, Hungary.
Herbert TomasoFriedrich-Loeffler-Institut, Institute of Bacterial Infections and Zoonoses, Jena, Germany.
Sabine ZangeBundeswehr Institute of Microbiology, Munich, Germany.
Beathe Kiland GranerudNorwegian Institute of Public Health, Oslo, Norway.
Michal DrevinekNational Institute for Nuclear, Chemical and Biological Protection, Milin, Czech Republic.
Branko KokotovicNational Veterinary Institute, Technical University of Denmark, Frederiksberg, Denmark.
Matthias WittwerSpiez Laboratory, Federal Office for Civil Protection, Spiez, Switzerland.
Valentin PflügerMabritec AG, Riehen, Switzerland.
Antonino Di CaroMicrobiology Laboratory and Infectious Diseases Biorepository, L. Spallanzani National Institute for Infectious Diseases, Rome, Italy.
Maren StämmlerRobert Koch Institute, Proteomics and Spectroscopy (ZBS 6), Berlin, Germany.
Roland GrunowRobert Koch Institute, Highly Pathogenic Microorganisms (ZBS 2), Berlin, Germany.
Daniela JacobRobert Koch Institute, Highly Pathogenic Microorganisms (ZBS 2), Berlin, Germany JacobD@rki.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the case of a release of highly pathogenic bacteria (HPB), there is an urgent need for rapid, accurate, and reliable diagnostics. MALDI-TOF mass spectrometry is a rapid, accurate, and relatively inexpensive technique that is becoming increasingly important in microbiological diagnostics to complement classical microbiology, PCR, and genotyping of HPB. In the present study, the results of a joint exercise with 11 partner institutions from nine European countries are presented. In this exercise, 10 distinct microbial samples, among them five HPB, Bacillus anthracis, Brucella canis, Burkholderia mallei, Burkholderia pseudomallei, and Yersinia pestis, were characterized under blinded conditions. Microbial strains were inactivated by high-dose gamma irradiation before shipment. Preparatory investigations ensured that this type of inactivation induced only subtle spectral changes with negligible influence on the quality of the diagnosis. Furthermore, pilot tests on nonpathogenic strains were systematically conducted to ensure the suitability of sample preparation and to optimize and standardize the workflow for microbial identification. The analysis of the microbial mass spectra was carried out by the individual laboratories on the basis of spectral libraries available on site. All mass spectra were also tested against an in-house HPB library at the Robert Koch Institute (RKI). The averaged identification accuracy was 77% in the first case and improved to >93% when the spectral diagnoses were obtained on the basis of the RKI library. The compilation of complete and comprehensive databases with spectra from a broad strain collection is therefore considered of paramount importance for accurate microbial identification.

Indexed as

Laboratory Proficiency TestingBacteriaBacteriological TechniquesEuropeInternational CooperationSpectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

Identifiers

PMID26063856
PMCPMC4508426

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.